Kratz Barry LLP

General

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Cases75

Challenger50%

Patent Owner50%

NPE50%

Practice Areas

BiotechReexam/Aband.Transport., E-Comm.

Top Attorneys

Patrick J. CoyneNeal S. CohenPeter Kinsella

Elite Ratings

DCTPTABCAFC

Ratings

Please sign up or log in to access the advanced features of
Ex Parte Professional.

or Log in

Experience

Grade

Trend

DCT

PTAB

CAFC

Analytics

Lawyers

Cases

Ratings Trends

Practice Areas

Recent Dockets

Entered	Case	Description
10/24/24	Amicus Therapeutics US LLC v. Teva Pharmaceuticals USA Inc 1:22-CV-01461 ( D. DE )	CONSENT JUDGMENT and PERMANENT INJUNCTION as to Teva Pharmaceuticals USA, Inc. and Teva Pharmaceuticals, Inc. (See Consent Judgment for further details.) Signed by Judge Christopher J. Burke on 10/24/2024. (smg) (Entered: 10/24/2024)
10/11/24	Axsome Malta Ltd v. Alkem Laboratories Ltd 2:23-CV-20354 ( D. NJ )	ANSWER to Complaint Plaintiffs' Answer to Alkem's Counterclaims by AXSOME MALTA LTD., AXSOME THERAPEUTICS, INC.. (Attachments: # [1] Certificate of Service)(LIZZA, CHARLES) (Entered: 10/11/2024)
10/11/24	Axsome Malta Ltd v. Alkem Laboratories Ltd 2:23-CV-20354 ( D. NJ )	ANSWER to Complaint Plaintiffs' Answer to Aurobindo Pharma USA, Inc. and Aurobindo Pharma Limited's Counterclaims by AXSOME MALTA LTD., AXSOME THERAPEUTICS, INC.. (Attachments: # [1] Certificate of Service)(LIZZA, CHARLES) (Entered: 10/11/2024)
10/11/24	Axsome Malta Ltd v. Alkem Laboratories Ltd 2:23-CV-20354 ( D. NJ )	ANSWER to Complaint Plaintiffs' Answer to Hikma Pharmaceuticals USA Inc.'s Counterclaims by AXSOME MALTA LTD., AXSOME THERAPEUTICS, INC.. (Attachments: # [1] Certificate of Service)(LIZZA, CHARLES) (Entered: 10/11/2024)
10/11/24	Axsome Malta Ltd v. Alkem Laboratories Ltd 2:23-CV-20354 ( D. NJ )	ANSWER to Complaint Plaintiffs' Answer to Hetero USA Inc., Hetero Labs Limited Unit-V, and Hetero Labs Ltd.'s Counterclaims by AXSOME MALTA LTD., AXSOME THERAPEUTICS, INC.. (Attachments: # [1] Certificate of Service)(LIZZA, CHARLES) (Entered: 10/11/2024)
10/11/24	Axsome Malta Ltd v. Alkem Laboratories Ltd 2:23-CV-20354 ( D. NJ )	ANSWER to Complaint Plaintiffs' Answer to Alkem's Counterclaims by AXSOME MALTA LTD., AXSOME THERAPEUTICS, INC.. (Attachments: # [1] Certificate of Service)(LIZZA, CHARLES) (Entered: 10/11/2024)
10/09/24	In re: Entresto (Sacubitril/Valsartan) Patent Litigation 1:20-MD-02930 ( D. DE )	UNSECURED Bond for Injunction Pending Appeal, by Novartis Pharmaceuticals Corporation. (Silver, Daniel) Modified on 10/9/2024 (nms). (Entered: 10/09/2024)
10/08/24	In re: Xarelto (Rivaroxaban) ('310) Patent Litigation 1:21-MD-03017 ( D. DE )	STIPULATION to Extend Time - filed by Hetero Labs Limited. (Dorsney, Kenneth) Modified on 10/8/2024 (nms). (Entered: 10/08/2024)
10/08/24	Theravance Biopharma R&D IP LLC v. Eugia Pharma Specialties Ltd 1:23-CV-00926 ( D. NJ )	Transcript of Telephone Conference held on 10/3/2024, before Judge Karen M. Williams. Court Reporter: Sharon Ricci (267-249-8780). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Court Reporter Agency due, but not filed, by 10/29/2024. Redacted Transcript Deadline set for 11/8/2024. Release of Transcript Restriction set for 1/6/2025. (sms2) (Entered: 10/08/2024) Transcript of Telephone Conference held on 10/3/2024, before Judge Karen M. Williams. Court Reporter: Sharon Ricci (267-249-8780). NOTICE REGARDING (1) REDACTION OF PERSONAL IDENTIFIERS IN TRANSCRIPTS AND (2) MOTION TO REDACT AND SEAL: The parties have seven (7) calendar days to file with the Court a Notice of Intent to Request Redaction of this Transcript to comply with Fed.R.Civ.P.5.2(a) (personal identifiers). Parties seeking to redact and seal this Transcript, or portions thereof, pursuant to L.Civ.R. 5.3(g) must e-file a Motion to Redact and Seal utilizing the event `Redact and Seal Transcript/Digital Recording`. Redaction Request to Court Reporter Agency due, but not filed, by 10/29/2024. Redacted Transcript Deadline set for 11/8/2024. Release of Transcript Restriction set for 1/6/2025. (sms2) (Entered: 10/08/2024)
10/08/24	In re: Xarelto (Rivaroxaban) ('310) Patent Litigation 1:21-MD-03017 ( D. DE )	SO ORDERED, re [316] STIPULATION to Extend Time (*Reset Answer Deadlines: Hetero Labs Limited answer due 10/23/2024). Signed by Judge Richard G. Andrews on 10/8/2024. (nms) (Entered: 10/08/2024)